FDA Investigator Jason T Lovelady
Jason T Lovelady has conducted inspections on 21 sites in 1 countries as of 13 Dec 2011. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
21
Last Inspection Date:
13 Dec 2011
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Jason T Lovelady:
Aaron J Poloni,
Alexander M Kay,
Alicia M Weitzel,
Andrew K Haack, PhD,
Avery J Dennis,
Belinda E Clifton,
Brenda K Alford,
Brenda L Reihing,
Bruce R Burrell,
Bryce E Mansfield,
Camille Bennett Hoffman,
Catherine J Laufmann,
Ce'nedra M Martin,
Celia L Hutchinstein,
Colleen M Jones,
Crystal A Harlan,
David A Quale,
David J Gomes,
David L Hunsaker,
Dirk L Lincoln,
Dolores E Price,
Don A Brunssen,
Donald B Mckechnie,
Edward D Harris,
Elizabeth S Howell,
Gloria J Baca, MS,
Gordon T Wales,
Harmon M Blanch,
Heika R Tait,
Hugh A Grimoldby,
Ian J Thomson,
Isaiah D Isakson,
Jack L Christy,
James E Trabert,
Jean Brewer,
Jeanne M Weishaar,
Jeffrey N Gerdes,
Jennifer W Cheng Dobson,
Jessica B Clark,
Jim D Pressley,
Jinkee Mvila Binayug,
Jonathan T Little,
Kimberly Jproctor Jones,
Kristina M Phelps,
Lance W Bohm,
LCDR Ismael Olvera, IV,
Lisa A Bowden,
Lisa K Capron,
Lon A Cummings,
Lorna F Jones,
Lucy Severs,
Margo C Jones,
Mark E Imsland,
Mark E Moen,
Marsha L Mccauley,
Matthew R Barr,
Michael J Donovan,
Michael S Hudson,
Michael S Valenzuela,
Mikel T Wright,
Nancy E Byerly,
Nancy E Doyle,
Paul F Rader,
Paula J Wilkerson,
Peter Kessler, PhD,
Peter T Regan,
Rachelle M Deskins,
Rebecca A Sletner,
Richard G Runyon,
Rocco C Black,
Roger F Zabinski,
Ronald E Gill,
Ronald L Lahti,
Sandra K Wangen,
Sangeeta M Khurana, PhD,
Shelagh D Schopen,
Stacy A Schneider,
Stanley B Eugene, BS, BME,
Stephanie J Shaw,
Sunitha K Rajaram, PhD,
Thomas C Mclean, CFS,
Timothy D Evans,
Timothy S Williamson,
Vitaliy N Guyvan,
Willis L Hicks
Jason T Lovelady's Documents
Publish Date | Document Type | Title |
---|---|---|
May, 2011 | FDA 483 | Quinault Pride Seafood - Form 483, 2011-05-12 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more